Exhaled Breath Metabolomics and Airways Diseases

This podcast spotlights Owlstone Medical, a company out of Cambridge, UK which has developed technologies including the ReCIVA breath samples, Breath Biopsy, and FAIMS technology that have accelerated advancements in the collection and metabolomics analysis of exhaled breath volatile organic compounds or VOCs. These technologies are currently being used to investigate airway diseases including Asthma, COPD, IPF and Lung Cancer.
Billy Boyle
Owlstone Medical

Andrew Bishop
Wake Forest School of Medicine
© 2024 American Thoracic Society